Background The cause of PD at present remains unknown. A number of epidemiological
studies have been conducted across the globe to ascertain the disease burden and the …

Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and
amyotrophic lateral sclerosis, comprise a family of disorders characterized by progressive …

Abstract Alpha-synuclein (α-syn) has been suggested to have many functions including,
vesicle transport in neurons, transcriptional regulator, modulator of immune cell maturation …

Advanced glycation end-products (AGEs; eg, glyoxal, methylglyoxal or carboxymethyl-
lysine) are heterogenous group of toxic compounds synthesized in the body through both …

Parkinson's disease (PD) is a neurodegenerative disorder influenced by both genetic and
environmental factors. The mechanisms leading to neurodegeneration in PD are still under …

Importance Epidemiologic evidence suggests that hepatitis C virus (HCV) could be a risk
factor for Parkinson disease (PD), but treatment for HCV infection has never been …

Abstract α‐synucleinopathies, encompassing Parkinson's disease, dementia with Lewy
bodies, and multiple system atrophy, are devastating neurodegenerative diseases for which …

Velpatasvir is a newly FDA-approved inhibitor of hepatitis C virus (HCV) NS5A protein. We
performed this systematic review and meta-analysis to investigate the safety and efficacy of …

The hepatitis C virus (HCV) causes serious issues, affecting 71 million people globally. The
most common manifestations range from chronic hepatitis to liver cirrhosis, leading to …

Background The risk of parkinsonism after antiviral treatment against chronic hepatitis C
(CHC) is unclear. Objectives To investigate the association between CHC and parkinsonism …